Main Sector
Biotechnology - Therapeutics and Diagnostics
Subsectors
Antibodies
Drug delivery
Immunotherapy
Indications
Neoplasms / cancer / oncology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Products
In development: 14
On the market: 2
Description
BioArctic AB is a research-focused biopharmaceutical company developing therapies for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). The company’s lead product, Leqembi (lecanemab), is indicated for early Alzheimer’s disease. In addition to Leqembi, BioArctic maintains a research portfolio of antibody-based therapies targeting Parkinson's disease and ALS as well as additional projects against Alzheimer's disease....
